Survey Points To Biomarkers’ Emerging Role In Clinical Practice
inVentiv Health Consulting conducted a survey of 85 physicians (oncologists, n = 30; and non-oncologists, n = 55) in February 2017 to explore the views of physicians regarding the role of biomarkers and companion diagnostics in clinical practice.
You may also be interested in...
Personalized medicine is becoming the hallmark of care in oncology, but its use is also increasing in other therapeutic areas including inflammation, respiratory, infectious diseases and central nervous system disorders, as scientific understanding of these diseases advances. The expansion of companion diagnostics beyond oncology has impacts on dealmaking, clinical practice and the R&D pipeline.